Accueil Healthcare Drug Repurposing Service Providers Market is estimated to be worth over USD 1.2 billion by 2030

Drug Repurposing Service Providers Market is estimated to be worth over USD 1.2 billion by 2030

0
0
110

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

Type of Repurposing Approaches

  • Disease-centric approach
  • Target-centric approach
  • Drug-centric approach

Therapeutic Area

  • Same Therapeutic Area
  • Different Therapeutic Area

Type of Drug Molecule

  • Biologics
  • Small Molecule

Key Geographical Region

  • North America
  • Europe
  • Asia-Pacific

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Auxillis Pharma
  • ChemBio Discovery Solutions
  • Excelra
  • GVK Bio
  • Iris Pharma
  • Lantern Pharma
  • PanXome
  • Pharmacelera
  • Physiogenex
  • Smart Pharma
  • Socium
  • SOM Biotech

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations

6. Company Profiles

7.  Partnerships

8. Big Pharma Initiatives

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact on Drug Repurposing Service Providers Market

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing

14. Interview Transcripts

15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing

16. Appendix 2: Tabulated Data

17. Appendix 3: List of Companies and Organizations

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Charger d'autres articles liés
Charger d'autres écrits par rootsanalysis
Charger d'autres écrits dans Healthcare

Laisser un commentaire

Consulter aussi

Global Healthcare Digital Marketing Service Providers Market Development, Overview, and Forecast to 2030

Over time, various pharma players have taken advantage of these immersive technologies for…